Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hizra Farrukh"'
Autor:
Weijie Ma, Ruobing Xue, Zheng Zhu, Hizra Farrukh, Wenru Song, Tianhong Li, Lei Zheng, Chong-xian Pan
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-19 (2023)
Abstract Immunotherapy has become the central pillar of cancer therapy. Immune checkpoint inhibitors (ICIs), a major category of tumor immunotherapy, reactivate preexisting anticancer immunity. Initially, ICIs were approved only for advanced and meta
Externí odkaz:
https://doaj.org/article/da7f7c484f764fc5a1c80950a97cc28b
Autor:
Kevin Pan, Hizra Farrukh, Veera Chandra Sekhar Reddy Chittepu, Huihong Xu, Chong-xian Pan, Zheng Zhu
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-21 (2022)
Abstract Adoptive cell therapy with chimeric antigen receptor (CAR) immunotherapy has made tremendous progress with five CAR T therapies approved by the US Food and Drug Administration for hematological malignancies. However, CAR immunotherapy in sol
Externí odkaz:
https://doaj.org/article/919452a165e941f4aff22bd24ae2f4c5
Autor:
Chong-xian Pan, Kit S. Lam, Yuanpei Li, Rao Prabhala, Veera Chandra Sekhar Reddy Chittepu, Zhixiu Cao, Ruan Yuan, Wei Shi, Shaoming Zhu, Hizra Farrukh, Xiangdong Xue, Tzu-Yin Lin, Hongyong Zhang, Ai-Hong Ma, Zheng Zhu
Supplementary Figure from Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2055f8dac3e9e39ffdce31b4d0361ac
https://doi.org/10.1158/1078-0432.22489209
https://doi.org/10.1158/1078-0432.22489209
Autor:
Chong-xian Pan, Kit S. Lam, Yuanpei Li, Rao Prabhala, Veera Chandra Sekhar Reddy Chittepu, Zhixiu Cao, Ruan Yuan, Wei Shi, Shaoming Zhu, Hizra Farrukh, Xiangdong Xue, Tzu-Yin Lin, Hongyong Zhang, Ai-Hong Ma, Zheng Zhu
Purpose:Immune checkpoint inhibitors (ICI) in general have shown poor efficacy in bladder cancer. The purpose of this project was to determine whether photodynamic therapy (PDT) with bladder cancer–specific porphyrin-based PLZ4-nanoparticles (PNP)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb2a6cd86f3770d25f7589bde4d27b1
https://doi.org/10.1158/1078-0432.c.6532902.v1
https://doi.org/10.1158/1078-0432.c.6532902.v1
Autor:
Zheng Zhu, Ai-Hong Ma, Hongyong Zhang, Tzu-Yin Lin, Xiangdong Xue, Hizra Farrukh, Shaoming Zhu, Wei Shi, Ruan Yuan, Zhixiu Cao, Veera Chandra Sekhar Reddy Chittepu, Rao Prabhala, Yuanpei Li, Kit S. Lam, Chong-xian Pan
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 28, iss 21
Clin Cancer Res
Clin Cancer Res
Purpose: Immune checkpoint inhibitors (ICI) in general have shown poor efficacy in bladder cancer. The purpose of this project was to determine whether photodynamic therapy (PDT) with bladder cancer–specific porphyrin-based PLZ4-nanoparticles (PNP)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c6365c9e3a5213c7d851002cc2b449c
https://escholarship.org/uc/item/78t832sp
https://escholarship.org/uc/item/78t832sp
Autor:
Kevin Pan, Hizra Farrukh, Veera Chandra Sekhar Reddy Chittepu, Huihong Xu, Chong-xian Pan, Zheng Zhu
Publikováno v:
Journal of experimentalclinical cancer research : CR. 41(1)
Adoptive cell therapy with chimeric antigen receptor (CAR) immunotherapy has made tremendous progress with five CAR T therapies approved by the US Food and Drug Administration for hematological malignancies. However, CAR immunotherapy in solid tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff94fdd62b79652c30cc4a5666de3797
https://pubmed.ncbi.nlm.nih.gov/35361234
https://pubmed.ncbi.nlm.nih.gov/35361234
Autor:
Ahmad Iftikhar, Muhammad Bilal Ahmad, Muhammad Ashar Ali, Faryal Razzaq, Hizra Farrukh, Azka Latif, Pranali Santhoshini Pachika, Faiz Anwer
Publikováno v:
Blood. 136:43-44
Introduction: Multiple myeloma (MM) is a neoplastic proliferation of plasma cells. It is the second most common hematological malignancy in the US. Although it is associated with poor prognosis, newer therapies have improved outcomes in MM patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3857ee7db1b65f6e9aa28d52ceeba166
https://doi.org/10.1182/blood-2020-142903
https://doi.org/10.1182/blood-2020-142903
Autor:
Ebad Rehman, Syed Maaz Abdullah, Fajar Pasha, Asmat Ullah, Syed Ather Hussain, Imtisaal Waris, Hizra Farrukh, Alireza Setarehaseman, Faiz Anwer, Mohammad Ammad Ud Din
Publikováno v:
Blood. 136:34-34
Introduction: Isatuximab (ISA) is an anti-CD38 monoclonal antibody that has shown benefit in patients with relapsed/refractory multiple myeloma (RRMM) in combination regimens. This study focuses on the clinical utility and tolerability of ISA based t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e635dcde6b57e709490fc0b2c31af1a
https://doi.org/10.1182/blood-2020-140872
https://doi.org/10.1182/blood-2020-140872
Autor:
Zainab Mansoor, Hizra Farrukh, Shehrbano Rizvi, Muhammad Faheem, Haran Innocent, Ammad Fahim, Anish Khalil
Publikováno v:
Psychiatry Journal, Vol 2016 (2016)
Psychiatry Journal
Psychiatry Journal
Background. The biomedical care for cancer has not been complemented by psychosocial progressions in cancer care.Objectives. To find the prevalence of anxiety and depression amongst cancer patients in a hospital setting.Design and Setting. This cross
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01f1c2008bff10ac86e070b758e700e3
https://doaj.org/article/bc2aab81cf2c430e9b86da59614d3818
https://doaj.org/article/bc2aab81cf2c430e9b86da59614d3818